Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 7,301–7,325 of 27,380 studies, newest first · page 293 of 1096.

October 2023 8

  1. 2023-10-01

    Validation of 3- and 5-point severity scales to assess ARIA-E

    ✓ Peer-reviewed Treatments Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: Our study suggests that SSAE-3 and SSAE-5 are valid ARIA-E rating scales for use in routine clinical practice by experienced radiologists in specialized settings. +3 more findings

  2. 2023-10-01

    The amyloid cascade hypothesis: an updated critical review

    ✓ Peer-reviewed Treatments Brain : a journal of neurology

    Key finding: However, while Aβ may contribute to disease, genetic, clinical, imaging and biochemical data suggest a more complex aetiology. +2 more findings

  3. 2023-10-01

    Immune profiling of murine cardiac leukocytes identifies triggering receptor expressed on myeloid cells 2 as a novel mediator of hypertensive heart failure

    ✓ Peer-reviewed TREM2 and immune genetics Cardiovascular research

    Key finding: Our data provide an atlas of immunological alterations that can lead to improved diagnostic and therapeutic strategies for HFpEF. +4 more findings

  4. 2023-10-01
  5. 2023-10-01

    H - 09 Neighborhood Disadvantage, Education Quality, and Cognitive Function in Community-Dwelling Black and White Older Adults with Metabolic Syndrome

    ✓ Peer-reviewed Risk factors Archives of Clinical Neuropsychology

    Key finding: Neighborhood disadvantage was selectively associated with cognitive measures heavily influenced by executive function, namely using an efficient word generation strategy, and incorporating feedback to guide problem-solving. +4 more findings

  6. 2023-10-01

    Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity

    ✓ Peer-reviewed Tau biomarkers JAMA neurology

    Key finding: An increased tau positron emission tomography (PET) signal in the medial temporal lobe (MTL) has been observed in older individuals in the absence of amyloid-β (Aβ) pathology. +3 more findings

  7. 2023-10-01

    New Horizons: Gonadotropin-Releasing Hormone and Cognition

    ✓ Peer-reviewed Down syndrome and Alzheimer's The Journal of clinical endocrinology and metabolism

    Key finding: Two recent studies suggest that, in addition to controlling reproduction, the neurons in the brain that produce GnRH are also involved in the control of postnatal brain maturation, odor discrimination, and adult cognition. +1 more finding

  8. 2023-10-01

    Demographic and Clinical Characteristics Associated With Serum GFAP Levels in an Ethnically Diverse Cohort

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: A total of 1,156 Mexican American and 587 non-Hispanic White participants were included (mean age = 68 years, standard deviation = 10; 65% female). +1 more finding

September 2023 17

  1. 2023-09-30

    TDP-43 pathology is associated with increased tau burdens and seeding

    ✓ Peer-reviewed Brain tissue and pathology Molecular neurodegeneration

    Key finding: We found that AD cases with comorbid LATE-NC, AD(LATE-NC+), have increased burdens of pretangles and/or NFTs as well as increased brain levels of p-tau199, compared to AD(LATE-NC-) cases and controls. +4 more findings

  2. 2023-09-30

    Targeting immunometabolic pathways for combination therapy in Alzheimer's disease

    ✓ Peer-reviewed Treatments Alzheimer's & dementia (New York, N. Y.)

    Key finding: Despite successfully clearing amyloid from the brain, however, only modest symptomatic improvement has been demonstrated, and treatment-related side effects such as amyloid-related imaging abnormalities (ARIA) limit use for some. +2 more findings

  3. 2023-09-30

    Amyloid Precursor Protein and Alzheimer's Disease

    ✓ Peer-reviewed Disease mechanisms International journal of molecular sciences

    Key finding: Alzheimer's disease (AD) is one of the most common neurodegenerative disorders associated with age or inherited mutations. +1 more finding

  4. 2023-09-29

    Sleep duration and brain MRI measures: Results from the SOL-INCA MRI study

    ✓ Peer-reviewed Risk factors Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: The final analytic sample included n = 2334 participants. +4 more findings

  5. 2023-09-29

    The role of Lactobacillus in inflammatory bowel disease: from actualities to prospects

    ✓ Peer-reviewed Disease mechanisms Cell death discovery

    Key finding: Inflammatory Bowel Disease (IBD), a chronic nonspecific intestinal inflammatory disease, is comprised of Ulcerative Colitis (UC) and Crohn's Disease (CD). +4 more findings

  6. 2023-09-28

    Air pollution, glymphatic impairment, and Alzheimer's disease

    ✓ Peer-reviewed Risk factors Trends in neurosciences

    Key finding: This opinion article examines the hypothesis that air pollution-induced impairment of glymphatic clearance represents a crucial etiological event in the development of AD. +4 more findings

  7. 2023-09-28

    Resting-State Functional Connectivity Difference in Alzheimer's Disease and Mild Cognitive Impairment Using Threshold-Free Cluster Enhancement

    ✓ Peer-reviewed Brain scans and imaging Diagnostics (Basel, Switzerland)

    Key finding: The study suggests that alterations in functional connectivity in these networks may contribute to cognitive deficits observed in AD and MCI. +1 more finding

  8. 2023-09-28

    A multidomain intervention against cognitive decline in an at-risk-population in Germany: Results from the cluster-randomized AgeWell.de trial

    ✓ Peer-reviewed Prevention trials Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: The intervention did not improve global cognitive performance. +1 more finding

  9. 2023-09-28

    Personal Health Planning in Adult-Child Former Caregivers of Parents Living With Dementia

    ✓ Peer-reviewed Health systems and care delivery American Journal of Health Promotion

    Key finding: Caregiving for a parent living with dementia (PLWD) shapes former caregivers’ personal health planning. +1 more finding

  10. 2023-09-28

    Addressing the Chronic Pain-Early Cognitive Decline Comorbidity Among Older Adults: Protocol for the Active Brains Remote Efficacy Trial

    ✓ Peer-reviewed Treatments JMIR research protocols

    Key finding: We are conducting a single-blinded, National Institutes of Health stage-2, randomized clinical trial to establish the efficacy of AB versus a time-matched and dose-matched education control (Health Enhancement Program [HEP]) in improving self-reported and objective outcomes of physical, cognitive, and emotional functions in 260 participants. +2 more findings

  11. 2023-09-27

    Associations between multimorbidity burden and Alzheimer's pathology in older adults without dementia: the CABLE study

    ✓ Peer-reviewed Tau biomarkers Neurobiology of aging

    Key finding: Studies have shown that multimorbidity may be associated with the Alzheimer's disease (AD) stages, but it has not been fully characterized in patients without dementia. +4 more findings

  12. 2023-09-27

    Utilization of P2Y12 Inhibitors in Older Adults With ST-Elevation Myocardial Infarction and Frailty

    ✓ Peer-reviewed Health systems and care delivery The American journal of cardiology

    Key finding: Choosing optimal P2Y12 inhibitor in frail older adults is challenging because they are at increased risk of both ischemic and bleeding events. +3 more findings

  13. 2023-09-25
  14. 2023-09-25

    Induction of proteasomal activity in mammalian cells by lifespan-extending tRNA synthetase inhibitors

    ✓ Peer-reviewed Disease mechanisms GeroScience

    Key finding: We have recently shown that multiple tRNA synthetase inhibitors can greatly increase lifespan in multiple models by acting through the conserved transcription factor ATF4.

  15. 2023-09-25

    Monoclonal Antibody Treatments for Alzheimer's Disease: Aducanumab and Lecanemab

    ✓ Peer-reviewed Treatments Discoveries (Craiova, Romania)

    Key finding: In recent years, significant strides have been made in the development and subsequent clinical testing of disease-modifying therapies (DMTs) designed to potentially alter the underlying pathophysiology of AD.

  16. 2023-09-25

    Sex difference in brain functional connectivity of hippocampus in Alzheimer's disease

    ✓ Peer-reviewed Brain scans and imaging GeroScience

    Key finding: Prior research has shown that AD disproportionality affects females; females have a greater incidence rate, perform worse on a variety of neuropsychological tasks, and have greater total brain atrophy. +3 more findings

  17. 2023-09-25

    Plasma Aβ42/40 and cognitive variability are associated with cognitive function in Black Americans: Findings from the AA-FAIM cohort

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia (New York, N. Y.)

    Key finding: IICV was associated with concurrent/baseline performance on several outcomes but did not modify associations between age and cognitive decline. +3 more findings

Browse the library by subject, with the full score breakdown →